Pharmaceutical

FDA approves GSK’s Blujepa for uncomplicated UTIs

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and paediatric patients.

Mar 27, 2025 - 06:00
FDA approves GSK’s Blujepa for uncomplicated UTIs
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and paediatric patients.
Read the original article

Tags:

Previous Article

Unmatched quality in pharmaceutical logistics: Why it matters

Next Article

Big pharma faces headwinds in China as vaccine sales decline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

JP Morgan 2025: Incyte expects period of ‘defining catalysts’

JP Morgan 2025: Incyte expects period of ‘defining cata...

Jan 16, 2025

STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest

STAT+: Here are the cancer drugs Pfizer thinks could re...

Feb 29, 2024

STAT+: Mental illness, drug addiction go hand in glove, Biden’s drug czar tells lawmakers

STAT+: Mental illness, drug addiction go hand in glove,...

Jul 30, 2023